A world-unique study shows that screening with Zenicor ONE can save billions

Stockholm 14 November 2023

The health-economic results of the large Swedish screening study STROKETOP, in which the Zenicor solution has been used to screen for atrial fibrillation with the aim of preventing stroke, are now published in the latest issue of the medical journal European Heart Journal. The results in the scientifically reviewed article show that 3.6 billion Swedish Krona can be saved per year by offering ECG screening for atrial fibrillation with the Zenicor solution to the cohort of 75/76-year-olds in Swedish. This is the first study in the world that has shown a health economic benefit of screening for atrial fibrillation.